TY - JOUR
T1 - Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor
T2 - An In Situ Aldosterone Imaging Study
AU - Takizawa, Nae
AU - Tanaka, Susumu
AU - Nishimoto, Koshiro
AU - Sugiura, Yuki
AU - Suematsu, Makoto
AU - Ohe, Chisato
AU - Ohsugi, Haruyuki
AU - Mizuno, Yosuke
AU - Mukai, Kuniaki
AU - Seki, Tsugio
AU - Oki, Kenji
AU - Gomez-Sanchez, Celso E.
AU - Matsuda, Tadashi
N1 - Funding Information:
Acknowledgments: The authors are grateful to the patient and her parents for their cooperation and participation in this study. The authors would like to thank the Department of Pathology and Internal Medicine II at Kansai Medical University Hospital for their contribution to the diagnosis, and Masakazu Kohda (Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan) for exome sequencing and the analysis of the data. This study was also supported in part by Shimadzu Corporation, Kyoto, Japan.
Funding Information:
Funding: K.N. was supported by JSPS KAKENHI, grant number 18K09205. The infrastructure of imaging metabolomics was partly supported by a grant from Shimadzu Corporation. Please note, this corporation did not contribute to the study design and data analyses; thus, there are no conflicts of interests to declare. K.N. was also partly supported by a grant from the Ministry of Health, Labor, and Welfare, Japan (20FC1020). Dr. Celso E. Gomez-Sanchez was supported by the R01 HL144847 grant, from the National Heart, Lung, and Blood Institute, the 1U54GM115428 grant from the National Institute of General Medical Sciences, and the BX004681 grant from the Department of Veteran Affairs.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/1
Y1 - 2022/1
N2 - Primary aldosteronism is most often caused by aldosterone-producing adenoma (APA) and bi-lateral adrenal hyperplasia. Most APAs are caused by somatic mutations of various ion channels and pumps, the most common being the inward-rectifying potassium channel KCNJ5. Germ line mutations of KCNJ5 cause familial hyperaldosteronism type 3 (FH3), which is associated with severe hyperaldosteronism and hypertension. We present an unusual case of FH3 in a young woman, first diagnosed with primary aldosteronism at the age of 6 years, with bilateral adrenal hyperplasia, who underwent unilateral adrenalectomy (left adrenal) to alleviate hyperaldosteronism. However, her hyperaldosteronism persisted. At the age of 26 years, tomography of the remaining adrenal revealed two different adrenal tumors, one of which grew substantially in 4 months; therefore, the adrenal gland was removed. A comprehensive histological, immunohistochemical, and molecular evaluation of various sections of the adrenal gland and in situ visualization of aldosterone, using matrix-assisted laser desorption/ionization imaging mass spectrometry, was performed. Aldosterone synthase (CYP11B2) immunoreactivity was observed in the tumors and adrenal gland. The larger tumor also harbored a somatic β-catenin activating mutation. Aldosterone visualized in situ was only found in the subcapsular regions of the adrenal and not in the tumors. Collectively, this case of FH3 presented unusual tumor development and histological/molecular findings.
AB - Primary aldosteronism is most often caused by aldosterone-producing adenoma (APA) and bi-lateral adrenal hyperplasia. Most APAs are caused by somatic mutations of various ion channels and pumps, the most common being the inward-rectifying potassium channel KCNJ5. Germ line mutations of KCNJ5 cause familial hyperaldosteronism type 3 (FH3), which is associated with severe hyperaldosteronism and hypertension. We present an unusual case of FH3 in a young woman, first diagnosed with primary aldosteronism at the age of 6 years, with bilateral adrenal hyperplasia, who underwent unilateral adrenalectomy (left adrenal) to alleviate hyperaldosteronism. However, her hyperaldosteronism persisted. At the age of 26 years, tomography of the remaining adrenal revealed two different adrenal tumors, one of which grew substantially in 4 months; therefore, the adrenal gland was removed. A comprehensive histological, immunohistochemical, and molecular evaluation of various sections of the adrenal gland and in situ visualization of aldosterone, using matrix-assisted laser desorption/ionization imaging mass spectrometry, was performed. Aldosterone synthase (CYP11B2) immunoreactivity was observed in the tumors and adrenal gland. The larger tumor also harbored a somatic β-catenin activating mutation. Aldosterone visualized in situ was only found in the subcapsular regions of the adrenal and not in the tumors. Collectively, this case of FH3 presented unusual tumor development and histological/molecular findings.
KW - Adrenal tumor
KW - CYP11B2
KW - Familial hyperaldosteronism type 3
KW - KCNJ5
KW - MALDI-IMS
KW - β-catenin
UR - http://www.scopus.com/inward/record.url?scp=85122707689&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122707689&partnerID=8YFLogxK
U2 - 10.3390/cimb44010010
DO - 10.3390/cimb44010010
M3 - Article
C2 - 35723389
AN - SCOPUS:85122707689
SN - 1467-3037
VL - 44
SP - 128
EP - 138
JO - Current Issues in Molecular Biology
JF - Current Issues in Molecular Biology
IS - 1
ER -